Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
https://doi.org/10.21256/zhaw-19725| Publikationstyp: | Beitrag in wissenschaftlicher Zeitschrift |
| Art der Begutachtung: | Peer review (Publikation) |
| Titel: | Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials |
| Autor/-in: | Hengartner, Michael Pascal Jakobsen, Janus C. Sørensen, Anders Plöderl, Martin |
| et. al: | No |
| DOI: | 10.1371/journal.pone.0229381 10.21256/zhaw-19725 |
| Erschienen in: | PLOS ONE |
| Band(Heft): | 15 |
| Heft: | 2 |
| Seite(n): | e0229381 |
| Erscheinungsdatum: | 2020 |
| Verlag / Hrsg. Institution: | Public Library of Science |
| ISSN: | 1932-6203 |
| Sprache: | Englisch |
| Fachgebiet (DDC): | 616.8: Neurologie und Krankheiten des Nervensystems |
| Zusammenfassung: | It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with the gold standard procedure, the Montgomery-Asberg Depression Rating-Scale (MADRS). |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/19725 |
| Volltext Version: | Publizierte Version |
| Lizenz (gemäss Verlagsvertrag): | CC BY 4.0: Namensnennung 4.0 International |
| Departement: | Angewandte Psychologie |
| Organisationseinheit: | Psychologisches Institut (PI) |
| Enthalten in den Sammlungen: | Publikationen Angewandte Psychologie |
Dateien zu dieser Ressource:
| Datei | Beschreibung | Größe | Format | |
|---|---|---|---|---|
| 2020_Hengartner-etal_New-generation-antidepressants.pdf | 898.34 kB | Adobe PDF |  Öffnen/Anzeigen |
Zur Langanzeige
Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. Plos One, 15(2), e0229381. https://doi.org/10.1371/journal.pone.0229381
Hengartner, M.P. et al. (2020) ‘Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials’, PLOS ONE, 15(2), p. e0229381. Available at: https://doi.org/10.1371/journal.pone.0229381.
M. P. Hengartner, J. C. Jakobsen, A. Sørensen, and M. Plöderl, “Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials,” PLOS ONE, vol. 15, no. 2, p. e0229381, 2020, doi: 10.1371/journal.pone.0229381.
HENGARTNER, Michael Pascal, Janus C. JAKOBSEN, Anders SØRENSEN und Martin PLÖDERL, 2020. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. PLOS ONE. 2020. Bd. 15, Nr. 2, S. e0229381. DOI 10.1371/journal.pone.0229381
Hengartner, Michael Pascal, Janus C. Jakobsen, Anders Sørensen, and Martin Plöderl. 2020. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One 15 (2): e0229381. https://doi.org/10.1371/journal.pone.0229381.
Hengartner, Michael Pascal, et al. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One, vol. 15, no. 2, 2020, p. e0229381, https://doi.org/10.1371/journal.pone.0229381.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.